You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API VEMURAFENIB

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing VEMURAFENIB

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Genentech Inc	ZELBORAF	vemurafenib	50242-090	CROSCARMELLOSE SODIUM	2032-06-06
Genentech Inc	ZELBORAF	vemurafenib	50242-090	FERRIC OXIDE RED	2032-06-06
Genentech Inc	ZELBORAF	vemurafenib	50242-090	HYDROXYPROPYL CELLULOSE	2032-06-06
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for VEMURAFENIB

Excipient focus: CROSCARMELLOSE SODIUM

VEMURAFENIB drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

VEMURAFENIB drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

VEMURAFENIB drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 16070722

VEMURAFENIB drug variants containing HYPROMELLOSE ACETATE SUCCINATE 16070722

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 16070722

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 3350

VEMURAFENIB drug variants containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing POLYETHYLENE GLYCOL 3350

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

VEMURAFENIB drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

VEMURAFENIB drug variants containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

VEMURAFENIB drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Genentech Inc	vemurafenib	50242-090
>Company	>Ingredient	>NDC

VEMURAFENIB drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.